# Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life

> **NCT02111135** · PHASE2 · COMPLETED · sponsor: **Vaxtrials S.A.** · enrollment: 240 (actual)

## Conditions studied

- Polio

## Interventions

- **BIOLOGICAL:** b-OPV
- **BIOLOGICAL:** m-OPV2
- **BIOLOGICAL:** m-IPV HD
- **BIOLOGICAL:** t-IPV

## Key facts

- **NCT ID:** NCT02111135
- **Lead sponsor:** Vaxtrials S.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-09
- **Final completion:** 2015-03
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2015-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111135, "Safety Study of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) in Infants Early in Life". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02111135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*